Author Correction: Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial

Brendan Conlon^{1

2

3}, Caroline Hamilton¹, Emma Meade¹, Sook Ling Leong¹, Ciara O Connor¹, Berthold Langguth^{4

5}, Sven Vanneste^{6

7}, Deborah A Hall^{8

9

10}, Stephen Hughes¹, Hubert H Lim^{11

12

13}

Affiliations

¹ Neuromod Devices Limited, Dublin, D08 R2YP, Ireland.
² School of Medicine, Trinity College Dublin, Dublin, D02 R590, Ireland.
³ Department of Otolaryngology, St. James's Hospital, Dublin, D08 NHY1, Ireland.
⁴ Department of Psychiatry and Psychotherapy, University of Regensburg, 93053, Regensburg, Germany.
⁵ Interdisciplinary Tinnitus Center of the University of Regensburg, 93053, Regensburg, Germany.
⁶ Trinity Institute for Neuroscience and Global Brain Health Institute, School of Psychology, Trinity College Dublin, Dublin, D02 PN40, Ireland.
⁷ Lab for Clinical and Integrative Neuroscience, School of Behavioral and Brain Sciences, The University of Texas at Dallas, Dallas, 75080, USA.
⁸ National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham, NG7 2UH, UK.
⁹ Hearing Sciences, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, NG7 2RD, UK.
¹⁰ School of Social Sciences, Heriot-Watt University Malaysia, 62200, Wilayah Persekutuan Putrajaya, Malaysia.
¹¹ Neuromod Devices Limited, Dublin, D08 R2YP, Ireland. hubert.lim@neuromoddevices.com.
¹² Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, 55455, USA. hubert.lim@neuromoddevices.com.
¹³ Department of Biomedical Engineering, University of Minnesota, 312 Church Street S.E., NHH 7-105, Minneapolis, MN, 55455, USA. hubert.lim@neuromoddevices.com.

Published Erratum

Brendan Conlon et al. Sci Rep. 2023.

. 2023 Jul 10;13(1):11152.

doi: 10.1038/s41598-023-38312-5.

¹ Neuromod Devices Limited, Dublin, D08 R2YP, Ireland.
² School of Medicine, Trinity College Dublin, Dublin, D02 R590, Ireland.
³ Department of Otolaryngology, St. James's Hospital, Dublin, D08 NHY1, Ireland.
⁴ Department of Psychiatry and Psychotherapy, University of Regensburg, 93053, Regensburg, Germany.
⁵ Interdisciplinary Tinnitus Center of the University of Regensburg, 93053, Regensburg, Germany.
⁶ Trinity Institute for Neuroscience and Global Brain Health Institute, School of Psychology, Trinity College Dublin, Dublin, D02 PN40, Ireland.
⁷ Lab for Clinical and Integrative Neuroscience, School of Behavioral and Brain Sciences, The University of Texas at Dallas, Dallas, 75080, USA.
⁸ National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham, NG7 2UH, UK.
⁹ Hearing Sciences, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, NG7 2RD, UK.
¹⁰ School of Social Sciences, Heriot-Watt University Malaysia, 62200, Wilayah Persekutuan Putrajaya, Malaysia.
¹¹ Neuromod Devices Limited, Dublin, D08 R2YP, Ireland. hubert.lim@neuromoddevices.com.
¹² Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, 55455, USA. hubert.lim@neuromoddevices.com.
¹³ Department of Biomedical Engineering, University of Minnesota, 312 Church Street S.E., NHH 7-105, Minneapolis, MN, 55455, USA. hubert.lim@neuromoddevices.com.

No abstract available

Erratum for

Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.
Conlon B, Hamilton C, Meade E, Leong SL, O Connor C, Langguth B, Vanneste S, Hall DA, Hughes S, Lim HH. Conlon B, et al. Sci Rep. 2022 Jun 30;12(1):10845. doi: 10.1038/s41598-022-13875-x. Sci Rep. 2022. PMID: 35773272 Free PMC article. Clinical Trial.